产品详情
靶点信息
VEGFR2 | Flk1 | FGFR1 | VEGFR1 | |
25 nM | 89 nM | 148 nM | 380 nM |
In vitro (25°C) | DMSO | 83 mg/mL (188 mM) | |
Water | Insoluble | ||
Ethanol | 83 mg/mL (188 mM) | ||
In vivo | 0.5% methylcellulose+0.2% Tween 80 | 9 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.65 mL | 113.25 mL | 226.5 mL |
0.5 mM | 4.53 mL | 22.65 mL | 45.3 mL |
1 mM | 2.27 mL | 11.33 mL | 22.65 mL |
5 mM | 0.45 mL | 2.27 mL | 4.53 mL |
*The above data is based on the productmolecular weight 441.5. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10162 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 441.5 |
Formula | C22H24FN5O4 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 649735-63-7 |
Synonyms | BMS582664 |
SMILES | CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)OC(=O)[C@H](C)N)C |
产品资料
产品标签
Product Questions
Product Questions
Brivanib (BMS-540215)
Brivanib (BMS-540215)是一种VEGFR-2抑制剂,IC50为25 nM,Ki为26 nM。
Pazopanib (GW-786034)
Pazopanib (GW-786034)是VEGFR-1,VEGFR-2,VEGFR-3,PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂,可阻…
Imatinib (Gleevec)
Imatinib (Gleevec)是一种多靶点酪氨酸激酶抑制剂,抑制v-Abl、c-Kit和PDGFR的IC50分别为0.6,0.1和0.1 μM。
Telatinib (BAY 57-9352)
Telatinib (BAY 57-9352)是一种口服的血管内皮生长因子受体2和3(VEGFR2/3)和血小板衍生的生长因子受体β酪氨酸…
Bibf1120 (Nintedanib)
Bibf1120 (Nintedanib)是一种新型的三联血管激酶抑制剂,可同时抑制三种生长因子受体:VEGFR,PDGF和FGFR。